Literature DB >> 7032569

Interaction of nitroimidazole drugs with DNA in vitro: structure-activity relationships.

R J Knox, R C Knight, D I Edwards.   

Abstract

An electrolytic reduction system has been developed to model the cytotoxic action of a range of nitroimidazole drugs against DNA hypoxic cells or anaerobic microorganisms. THe degree of damage induced by these drugs (measured as the release of [14C]-dT from DNA) and their relative rates of reduction have been correlated with their redox potentials. The results show that the correlation of drug-induced damage and electron affinity is related to the amount of drug reduced, and supports the hypothesis that at the molecular level the cytotoxic mechanism of reduced nitroimidazoles is identical in hypoxic mammalian cells, bacteria and protozoa.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7032569      PMCID: PMC2010832          DOI: 10.1038/bjc.1981.261

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Activity-electroreduction relationship of antimicrobial metronidazole analogues.

Authors:  Y W Chien; S S Mizuba
Journal:  J Med Chem       Date:  1978-04       Impact factor: 7.446

2.  The selective toxicity of antimicrobial nitroheterocyclic drugs.

Authors:  D I Edwards; M Dye; H Carne
Journal:  J Gen Microbiol       Date:  1973-05

3.  The interaction of reduced metronidazole with DNA.

Authors:  R C Knight; I M Skolimowski; D I Edwards
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

4.  The activity of nitro-compounds against Bacteroides fragilis is related to their electron affinity.

Authors:  A V Reynolds
Journal:  J Antimicrob Chemother       Date:  1981-08       Impact factor: 5.790

5.  Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers.

Authors:  G E Adams; I R Flockhart; C E Smithen; I J Stratford; P Wardman; M E Watts
Journal:  Radiat Res       Date:  1976-07       Impact factor: 2.841

6.  Screening for the mutagenicity of nitro-group containing hypoxic cell radiosensitizers using Salmonella typhimurium strains TA 100 and TA98.

Authors:  J B Chin; D M Sheinin; A M Rauth
Journal:  Mutat Res       Date:  1978-09       Impact factor: 2.433

7.  Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.

Authors:  I R Flockhart; P Large; D Troup; S L Malcolm; T R Marten
Journal:  Xenobiotica       Date:  1978-02       Impact factor: 1.908

8.  Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency.

Authors:  G E Adams; E D Clarke; I R Flockhart; R S Jacobs; D S Sehmi; I J Stratford; P Wardman; M E Watts; J Parrick; R G Wallace; C E Smithen
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1979-02

9.  Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.

Authors:  I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

10.  Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine.

Authors:  E J Hall; M Astor; C Geard; J Biaglow
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

View more
  5 in total

Review 1.  Chagas disease.

Authors:  A R L Teixeira; N Nitz; M C Guimaro; C Gomes; C A Santos-Buch
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

2.  Synthesis and characterization of a hypoxia-sensitive MRI probe.

Authors:  Federico A Rojas-Quijano; Gyula Tircsó; Enikő Tircsóné Benyó; Zsolt Baranyai; Huan Tran Hoang; Ferenc K Kálmán; Praveen K Gulaka; Vikram D Kodibagkar; Silvio Aime; Zoltán Kovács; A Dean Sherry
Journal:  Chemistry       Date:  2012-06-27       Impact factor: 5.236

3.  Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group.

Authors:  L Jokipii; A M Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

4.  Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis.

Authors:  S N Moreno; R Docampo
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

5.  Neurotoxicosis in 4 cats receiving ronidazole.

Authors:  Terri W Rosado; Andrew Specht; Stanley L Marks
Journal:  J Vet Intern Med       Date:  2007 Mar-Apr       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.